Clinicians should understand the rare, but significant, phenomenon of prostate cancer
invasion into the lumbosacral plexus, mimicking neurofibroma.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical Genitourinary CancerAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Management of patients with biochemical recurrence after local therapy for prostate cancer.Hematol Oncol Clin North Am. 2013; 27: 1205-1219
- Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.Hum Pathol. 2000; 31: 578-583
- Spinal cord compression in metastatic prostate cancer.Eur Urol. 2003; 44: 527-532
- Recurrent prostatic adenocarcinoma with perineural spread to the lumbosacral plexus and sciatic nerve: comparing high resolution MRI with torso and endorectal coils and F-18 FDG and C-11 choline PET/CT.Abdom Imaging. 2013; 38: 1155-1160
- Prostate cancer with perineural spread and dural extension causing bilateral lumbosacral plexopathy: case report.J Neurosurg. 2015; 122: 778-783
- Adenocarcinoma of the prostate involving the lumbosacral plexus: MRI evidence to support direct perineural spread.Acta Neurochir. 2010; 152: 1567-1576
- Neoplastic lumbosacral radiculoplexopathy in prostate cancer by direct perineural spread: an unusual entity.Muscle Nerve. 2006; 34: 659-665
- Imaging features and clinical significance of perineural spread or extension of head and neck tumors.Radiographics. 1998; 18 (quiz 147): 97-110
- Detection and analysis of beta-catenin mutations in prostate cancer.Prostate. 2000; 45: 323-334
- Beta-catenin signaling and cancer.Bioessays. 1999; 21: 1021-1030
- Interruption of beta-catenin signaling reduces neurogenesis in Alzheimer's disease.J Neurosci. 2009; 29: 6545-6557
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference.Int J Radiat Oncol Biol Phys. 2006; 65: 965-974
- Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions.Clin Adv Hematol Oncol. 2013; 11: 14-23
- The effect of PSA doubling time (PSADT) and Gleason score on the PSA at the time of first metastasis in men with biochemical recurrence after prostatectomy.J Clin Oncol. 2011; 29 (abstract 16)
- Features of unusual metastases from prostate cancer.Br J Radiol. 1999; 72: 933-941
- Frequency of brain metastases from prostate cancer: an 18-year single-institution experience.J Neurooncol. 2013; 111: 163-167
- Baseline perineural invasion is associated with shorter time to progression in men with prostate cancer undergoing active surveillance: results from the REDEEM study.J Urol. 2015; 194: 1258-1263
- Perineural invasion in prostate biopsy specimens is associated with increased bone metastasis in prostate cancer.Prostate. 2015; 75: 1783-1789
- Perineural invasion and spread in head and neck cancer.Expert Rev Anticancer Ther. 2012; 12: 359-371
- A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer.Cancer Genet. 2013; 206: 1-11
- Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.Science. 2005; 310: 644-648
- Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis.Nat Genet. 2009; 41: 524-526
- Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancers.Proc Natl Acad Sci U S A. 2012; 109: 19368-19373
- Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.Cancer Res. 1999; 59: 4291-4296
- E17K substitution in AKT1 in prostate cancer.Br J Cancer. 2010; 102: 1491-1494
- Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression.Mod Pathol. 2009; 22: 1083-1093
- Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model.Proc Natl Acad Sci U S A. 2003; 100: 7841-7846
- The oncogenic activation of beta-catenin.Curr Opin Genet Dev. 1999; 9: 15-21
- The Wnt pathway destabilizes adherens junctions and promotes cell migration via beta-catenin and its target gene cyclin D1.FEBS Open Bio. 2012; 2: 26-31
- Beta-catenin mutations in human prostate cancer.Cancer Res. 1998; 58: 2520-2523
- Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules).Am J Surg Pathol. 2005; 29: 1322-1329
- Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.Ann Hepatol. 2015; 14: 64-74
- Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers.Mol Syst Biol. 2013; 9: 637
- Wnt signalling regulates adult hippocampal neurogenesis.Nature. 2005; 437: 1370-1375
- Beta-catenin-mediated Wnt signaling regulates neurogenesis in the ventral telencephalon.Nat Neurosci. 2008; 11: 1383-1391
- CTNNB1 (beta-catenin) mutation is rare in brain tumours but involved as a sporadic event in a brain metastasis.Acta Neurochir. 2009; 151: 1107-1111
Article info
Publication history
Published online: February 23, 2016
Accepted:
February 14,
2016
Received in revised form:
February 5,
2016
Received:
January 19,
2016
Identification
Copyright
© 2016 Elsevier Inc. All rights reserved.
